PROCTER & GAMBLE HEALTH
Back to Cashflow Statement
|
PROCTER & GAMBLE HEALTH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Jun2024 | Mar2024 | Jun2023 | Jun2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-235 Cr | ₹-418 Cr | ₹-418 Cr | ₹-98 Cr | ₹-289 Cr |
What is the latest Cash Flow from Financing Activities ratio of PROCTER & GAMBLE HEALTH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-235 Cr |
| Jun2024 | ₹-418 Cr |
| Mar2024 | ₹-418 Cr |
| Jun2023 | ₹-98 Cr |
| Jun2022 | ₹-289 Cr |
How is Cash Flow from Financing Activities of PROCTER & GAMBLE HEALTH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-235 Cr | Negative | |
| Jun2024 | ₹-418 Cr | Negative | |
| Mar2024 | ₹-418 Cr | Negative | |
| Jun2023 | ₹-98 Cr | Negative | |
| Jun2022 | ₹-289 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PROCTER & GAMBLE HEALTH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PROCTER & GAMBLE HEALTH | ₹10,360.2 Cr | 0.9% | 18.6% | 6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PROCTER & GAMBLE HEALTH | 0.9% |
18.6% |
6% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses